| Name | Weis Pharmacy #123 |
|---|---|
| Organization Name | Weis Markets Inc |
| Location | 4126 E Joppa Rd, Baltimore, Maryland 21236 |
| Type | Pharmacy |
| Phone | (410) 529-3045 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A new study has confirmed that the drug, ivacaftor (VX-770), significantly improves lung function in some people with cystic fibrosis (CF). The results of the phase III clinical trial study, "A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation," led by Bonnie W. Ramsey, MD of Seattle Children's Research Institute and the University of Washington, were published today in the New England Journal of Medicine.
An international team from the University of Alabama at Birmingham and University College London and Queens University Belfast in the United Kingdom developed a cell culture model that could help to develop earlier treatment strategies for age-related macular degeneration, the third most prevalent cause of vision loss worldwide.
Lexicon Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, $95,000,000 of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Lexicon also intends to grant the underwriters a 30-day option to purchase up to an additional $14,250,000 of common stock to cover over-allotments, if any.
Hospital ratings are intended to help patients decide where to get medical care and encourage hospitals to improve the quality of their services. They also can influence how insurance companies negotiate contracts for reimbursing hospitals.
Ulysses Pharma has announced the issuance of US Patent 7,410,974, covering its novel class of antibiotics which target drug resistant bacteria.
› Verified 7 days ago
| NPI Number | 1619900941 |
| Organization Name | WEIS MARKETS INC |
| Doing Business As | WEIS PHARMACY |
| Type | Pharmacy |
| Address | 4126 E Joppa Rd, Baltimore, MD 21236 |
| Phone Number | 410-529-3045 |
News Archive
A new study has confirmed that the drug, ivacaftor (VX-770), significantly improves lung function in some people with cystic fibrosis (CF). The results of the phase III clinical trial study, "A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation," led by Bonnie W. Ramsey, MD of Seattle Children's Research Institute and the University of Washington, were published today in the New England Journal of Medicine.
An international team from the University of Alabama at Birmingham and University College London and Queens University Belfast in the United Kingdom developed a cell culture model that could help to develop earlier treatment strategies for age-related macular degeneration, the third most prevalent cause of vision loss worldwide.
Lexicon Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, $95,000,000 of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Lexicon also intends to grant the underwriters a 30-day option to purchase up to an additional $14,250,000 of common stock to cover over-allotments, if any.
Hospital ratings are intended to help patients decide where to get medical care and encourage hospitals to improve the quality of their services. They also can influence how insurance companies negotiate contracts for reimbursing hospitals.
Ulysses Pharma has announced the issuance of US Patent 7,410,974, covering its novel class of antibiotics which target drug resistant bacteria.
› Verified 7 days ago
News Archive
A new study has confirmed that the drug, ivacaftor (VX-770), significantly improves lung function in some people with cystic fibrosis (CF). The results of the phase III clinical trial study, "A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation," led by Bonnie W. Ramsey, MD of Seattle Children's Research Institute and the University of Washington, were published today in the New England Journal of Medicine.
An international team from the University of Alabama at Birmingham and University College London and Queens University Belfast in the United Kingdom developed a cell culture model that could help to develop earlier treatment strategies for age-related macular degeneration, the third most prevalent cause of vision loss worldwide.
Lexicon Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, $95,000,000 of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Lexicon also intends to grant the underwriters a 30-day option to purchase up to an additional $14,250,000 of common stock to cover over-allotments, if any.
Hospital ratings are intended to help patients decide where to get medical care and encourage hospitals to improve the quality of their services. They also can influence how insurance companies negotiate contracts for reimbursing hospitals.
Ulysses Pharma has announced the issuance of US Patent 7,410,974, covering its novel class of antibiotics which target drug resistant bacteria.
› Verified 7 days ago
Santa Monica Pharmacy And Medical S Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4300 Belair Rd, Baltimore, Maryland 21206 Phone: (410) 617-0116 | |
Rite Aid Pharmacy 00349 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4380 Park Heights Ave, Baltimore, Maryland 21215 Phone: (410) 664-8644 | |
Rite Aid Pharmacy 02214 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2855 Smith Ave, Baltimore, Maryland 21209 Phone: (410) 484-3200 | |
Rite Aid Pharmacy 00356 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3804 Liberty Heights Ave, Baltimore, Maryland 21215 Phone: (410) 367-5151 | |
Rite Aid Pharmacy 00385 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5804 Ritchie Hwy, Baltimore, Maryland 21225 Phone: (410) 789-3775 |